Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Oct 2024 for Annexin Pharmaceuticals AB (publ), €44k. Read the official filing
Filing timeline
BuySaleAnna Frostegård
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anna Frostegård: trading record in brief
All filings by Anna Frostegård on record concern Annexin Pharmaceuticals AB (publ). We count 4 filings; the first trade dates from 18 December 2023 and the latest from 23 October 2024.
The open-market record is one-sided, with 1 purchase worth €44k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2024: 1 purchase and no sales on the market.
On 24 October 2024 came the latest disclosure, an open-market purchase for €44k in Annexin Pharmaceuticals AB (publ). Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Anna Frostegård
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
5,000,000 shares@ SEK 0.1027.1% of flowTeckningsoptionFI:csv-800ecd10f35bfbd8499b
Canonical exit: 21 Jan 2025 (T+90)
3,007,628 shares@ SEK 0.2540.6% of flowBTA (betald tecknad aktie)ISIN SE0009664154FI:csv-c913f158449b71ed9f31
2,910,622 shares@ SEK 0.2032.2% of flowBTA (betald tecknad aktie)ISIN SE0009664154FI:csv-1b80db317a7889ee1dcb
3 of 3 declarations
